Debenhams finance chief sells
A round-up of the biggest director deals today so far.
Debenhams finance director Christopher Woodhouse has sold £7.24m worth of shares in the department stores operator.
The share sales took place between 22 and 28 October. Woodhouse is left with 3.15m shares, which are equivalent to 0.24% of Debenhams. The previous trading activity in the shares was in December 2008 when Woodhouse bought 229,869 shares at a price of 23.33p each.
Woodhouse has been finance director of Debenhams since it refloated in May 2006. He was finance director of Debenhams Ltd from December 2003, after the company was taken private, until the flotation.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
This sale comes at a time when Texas Pacific Group sold its remaining 9.4% stake to Och Ziff Management for around £100m. In fact, Och Ziff acquired an additional 10m shares when it bought the TPG stake, which took its stake to 11.52%.
Debenhams, which has 144 department stores in the UK and Ireland, raised £323m in a placing and open offer at 80p a share in June.
Value: £56,500
Value: £7,241,032
Value: £1,292,500
Value: $304,630
Value: $304,630
Value: $304,630
Value: $304,630
Value: £241,384
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
Energy bills to rise by 1.2% in January 2025
Energy bills are set to rise 1.2% in the New Year when the latest energy price cap comes into play, Ofgem has confirmed
By Dan McEvoy Published
-
Should you invest in Trainline?
Ticket seller Trainline offers a useful service – and good prospects for investors
By Dr Matthew Partridge Published